Literature DB >> 12097244

Cultivation of plasmodium spp.

Frederick L Schuster1.   

Abstract

Cultivation of both human and non-human species of Plasmodium spp., the causal agent of malaria, has been a major research success, leading to a greater understanding of the parasite. Efforts at cultivating the organisms in vitro are complicated by the parasites' alternating between a human host and an arthropod vector, each having its own set of physiological, metabolic, and nutritional parameters. Life cycle stages of the four species that infect humans have been established in vitro. Of these four, P. falciparum remains the only species for which all stages have been cultured in vitro; different degrees of success have been achieved with the other human Plasmodium spp. The life cycle includes the exoerythrocytic stage (within liver cells), the erythrocytic stage (within erythrocytes or precursor reticulocytes), and the sporogonic stage (within the vector). Culture media generally consist of a basic tissue culture medium (e.g., minimal essential medium or RPMI 1640) to which serum and erythrocytes are added. Most of the efforts have been directed toward the stage found in the erythrocyte. This stage has been cultivated in petri plates or other growth vessels in a candle jar to generate elevated CO(2) levels or in a more controlled CO(2) atmosphere. Later developments have employed continuous-flow systems to reduce the labor-intensive nature of medium changing. The exoerythrocytic and sporogonic life cycle stages have also been cultivated in vitro. A number of avian, rodent, and simian malarial parasites have also been established in vitro. Although cultivation is of great help in understanding the biology of Plasmodium, it does not lend itself to use for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097244      PMCID: PMC118084          DOI: 10.1128/CMR.15.3.355-364.2002

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  90 in total

1.  Initial extracellular development in vitro of erythrocytic stages of malaria parasites (Plasmodium falciparum).

Authors:  W Trager; J Zung; M Tershakovec
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  An alternative to serum for cultivation of Plasmodium falciparum in vitro.

Authors:  S L Cranmer; C Magowan; J Liang; R L Coppel; B M Cooke
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 May-Jun       Impact factor: 2.184

3.  Plasmodium vivax: in vitro growth and reinvasion in red blood cells of Aotus nancymai.

Authors:  B Mons; W E Collins; J C Skinner; W van der Star; J J Croon; H J van der Kaay
Journal:  Exp Parasitol       Date:  1988-08       Impact factor: 2.011

4.  In vitro culture of the mosquito stages of Plasmodium falciparum.

Authors:  A Warburg; I Schneider
Journal:  Exp Parasitol       Date:  1993-03       Impact factor: 2.011

5.  Effect of low temperature on the in vitro growth of Plasmodium falciparum.

Authors:  M O Rojas; M Wasserman
Journal:  J Eukaryot Microbiol       Date:  1993 Mar-Apr       Impact factor: 3.346

6.  Sporogonic development of a malaria parasite in vitro.

Authors:  A Warburg; L H Miller
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

7.  Serum-free cultivation of Plasmodium falciparum gametocytes in vitro.

Authors:  A Lingnau; G Margos; W A Maier; H M Seitz
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

8.  Crithidia fasciculata as feeder cells for malaria parasites.

Authors:  F M Awad-el-Kariem; K J Hunter; G C Kirby; D C Warhurst
Journal:  Exp Parasitol       Date:  1995-02       Impact factor: 2.011

9.  Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth.

Authors:  A A Divo; T G Geary; N L Davis; J B Jensen
Journal:  J Protozool       Date:  1985-02

10.  Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells.

Authors:  P Grellier; D Rigomier; V Clavey; J C Fruchart; J Schrevel
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

View more
  37 in total

1.  PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.

Authors:  Maggie S Schlarman; Renee N Roberts; Michael M Kariuki; Alexis N LaCrue; Ruguang Ou; Brenda T Beerntsen
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  A microfluidic model for single-cell capillary obstruction by Plasmodium falciparum-infected erythrocytes.

Authors:  J Patrick Shelby; John White; Karthikeyan Ganesan; Pradipsinh K Rathod; Daniel T Chiu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-24       Impact factor: 11.205

3.  Optimizing the culture of Plasmodium falciparum in hollow fiber bioreactors.

Authors:  P Preechapornkul; K Chotivanich; M Imwong; A M Dondorp; S J Lee; N P J Day; N J White; S Pukrittayakamee
Journal:  Southeast Asian J Trop Med Public Health       Date:  2010-07       Impact factor: 0.267

4.  Diagnosis of mixed Plasmodium malariae and P. vivax infection in a development aid volunteer by examination of bone-marrow specimens by real-time PCR.

Authors:  Can Imirzalioglu; Nedim Soydan; Markus Schaller; Reinhard G Bretzel; Trinad Chakraborty; Eugen Domann
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 5.  Phenotypic Screens in Antimalarial Drug Discovery.

Authors:  Marisa L Hovlid; Elizabeth A Winzeler
Journal:  Trends Parasitol       Date:  2016-05-27

Review 6.  Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Authors:  Kei Katsuno; Jeremy N Burrows; Ken Duncan; Rob Hooft van Huijsduijnen; Takushi Kaneko; Kiyoshi Kita; Charles E Mowbray; Dennis Schmatz; Peter Warner; B T Slingsby
Journal:  Nat Rev Drug Discov       Date:  2015-10-05       Impact factor: 84.694

7.  Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria.

Authors:  Lisa Frueh; Yuexin Li; Michael W Mather; Qigui Li; Sovitj Pou; Aaron Nilsen; Rolf W Winter; Isaac P Forquer; April M Pershing; Lisa H Xie; Martin J Smilkstein; Diana Caridha; Dennis R Koop; Robert F Campbell; Richard J Sciotti; Mara Kreishman-Deitrick; Jane X Kelly; Brian Vesely; Akhil B Vaidya; Michael K Riscoe
Journal:  ACS Infect Dis       Date:  2017-09-27       Impact factor: 5.084

8.  Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.

Authors:  Tina Dasgupta; Penchit Chitnumsub; Sumalee Kamchonwongpaisan; Cherdsak Maneeruttanarungroj; Sara E Nichols; Theresa M Lyons; Julian Tirado-Rives; William L Jorgensen; Yongyuth Yuthavong; Karen S Anderson
Journal:  ACS Chem Biol       Date:  2009-01-16       Impact factor: 5.100

9.  Optimized high gradient magnetic separation for isolation of Plasmodium-infected red blood cells.

Authors:  Sebastian C Bhakdi; Annette Ottinger; Sangdao Somsri; Panudda Sratongno; Peeranad Pannadaporn; Pattamawan Chimma; Prida Malasit; Kovit Pattanapanyasat; Hartmut P H Neumann
Journal:  Malar J       Date:  2010-02-02       Impact factor: 2.979

10.  Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum.

Authors:  Aziza Akaddar; Cécile Doderer-Lang; Melissa R Marzahn; François Delalande; Marc Mousli; Karen Helle; Alain Van Dorsselaer; Dominique Aunis; Ben M Dunn; Marie-Hélène Metz-Boutigue; Ermanno Candolfi
Journal:  Cell Mol Life Sci       Date:  2009-12-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.